Deals, Partnering

Global Green, Inc. Signs Agreement with Merial for Evaluation of Salmonella Vaccine and License Option

Posted on 04 September 2013

Tags: , , ,

Global Green announces the signing of an agreement with Merial to conduct an internal evaluation of Global Green’s patented Salmogenics vaccine technology.

At the conclusion of the evaluation, Merial has the first option to enter into a license agreement with Global Green for the manufacture, distribution, and sale of the vaccine.

Salmogenics is the only patented salmonella vaccine injected into the egg before the chick is hatched.

The aim of the Salmogenics vaccine is to improve the immune system, health and welfare of the 40 billion broiler chickens in the world and to provide a healthier source of protein for humans in a more cost-effective manner.

Salmogenics is the only patented salmonella vaccine injected into the egg before the chick is hatched. Salmogenics significantly reduces the presence of salmonella in the chicken. Salmonella is an anaerobic bacteria that may enter the digestive tract of humans and other mammals in contaminated food and cause abdominal cramps and pain, violent vomiting and diarrhea or severe dehydration; it can also enter the bloodstream which may lead to death.

The aim of the Salmogenics vaccine is to improve the immune system, health and welfare of the 40 billion broiler chickens in the world and to provide a healthier source of protein for humans in a more cost-effective manner. Salmogenics testing has demonstrated a stronger immune system against salmonella as well as increased weight gain and reduced mortality in poultry. Salmogenics could lessen the need for use of antibiotics, an essential benefit to both the poultry industry and, ultimately, consumers.

For further deal information visit Current Agreements (subscription required)

Related

Read: latest life science partnering, M&A, financing and deal talk updates 

Report: Option & Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply